{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:56:52Z","timestamp":1790989012743,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168440","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:19:53Z","timestamp":1788016793000},"page":"168440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer single-cell atlas of immunotherapy response identifies ZNF385A as a regulator of immune evasion in small cell lung cancer"],"prefix":"10.1016","volume":"1873","author":[{"given":"Jiabao","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbadis.2026.168440_bb0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168440_bb0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.annonc.2019.10.021","article-title":"Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I\/III trial","volume":"31","author":"Mansfield","year":"2020","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","article-title":"Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies","volume":"13","author":"Zheng","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168440_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106454","article-title":"Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients","volume":"83","author":"Sun","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/09731296241262832","article-title":"Study on cantharidin reversing the drug-resistance of nonsmall cell lung cancer to DDP by regulating the expression of PD-L1","volume":"21","author":"Jin","year":"2025","journal-title":"Pharmacogn. Mag."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168440_bb0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168440_bb0045","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2159-8290.CD-23-0486","article-title":"Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer","volume":"14","author":"Murayama","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2026.168440_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111998","article-title":"Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy","volume":"132","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2026.168440_bb0055","article-title":"Natural killer cell immune checkpoints and their therapeutic targeting in cancer treatment","volume":"8","author":"Lin","year":"2025","journal-title":"Research (Wash D C)"},{"issue":"9","key":"10.1016\/j.bbadis.2026.168440_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bbadis.2026.168440_bb0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"Pt 2","key":"10.1016\/j.bbadis.2026.168440_bb0070","article-title":"Monoclonal antibody targeting CEACAM1 enhanced the response to anti-PD1 immunotherapy in non-small cell lung cancer","volume":"143","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168440_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00262-025-04006-2","article-title":"Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer","volume":"74","author":"Dora","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168440_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nri1804","article-title":"DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis","volume":"6","author":"Xu","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168440_bb0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.molcel.2022.12.031","article-title":"Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control","volume":"83","author":"Concannon","year":"2023","journal-title":"Mol. Cell"},{"issue":"7970","key":"10.1016\/j.bbadis.2026.168440_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-023-06069-6","article-title":"The complementarity of DDR, nucleic acids and anti-tumour immunity","volume":"619","author":"Kornepati","year":"2023","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.bbadis.2026.168440_bb0095","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1158\/0008-5472.CAN-23-0329","article-title":"NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling","volume":"83","author":"Ka","year":"2023","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168440_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2007.06.013","article-title":"Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation","volume":"130","author":"Das","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbadis.2026.168440_bb0105","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/MCB.01424-10","article-title":"Cooperative role of the RNA-binding proteins Hzf and HuR in p53 activation","volume":"31","author":"Nakamura","year":"2011","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0110","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1038\/s41467-025-58704-7","article-title":"Characterization of dsRNA binding proteins through solubility analysis identifies ZNF385A as a dsRNA homeostasis regulator","volume":"16","author":"Jiang","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168440_bb0115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","article-title":"Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer","volume":"39","author":"Chan","year":"2021","journal-title":"Cancer Cell"},{"issue":"5795","key":"10.1016\/j.bbadis.2026.168440_bb0120","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"10135","key":"10.1016\/j.bbadis.2026.168440_bb0125","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"issue":"6230","key":"10.1016\/j.bbadis.2026.168440_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-026-01455-5","article-title":"Management of hematological toxicities after BCMA-directed CAR-T cell therapy","volume":"16","author":"Cook","year":"2026","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168440_bb0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.bbadis.2026.168440_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr6132","article-title":"Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire","volume":"12","author":"Kehm","year":"2026","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168440_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.it.2014.12.001","article-title":"Confusing signals: recent progress in CTLA-4 biology","volume":"36","author":"Walker","year":"2015","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168440_bb0155","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","article-title":"Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis","volume":"24","author":"Savas","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168440_bb0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41419-024-07073-y","article-title":"Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates","volume":"15","author":"Shi","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02846-3","article-title":"CD28\/PD1 co-expression: dual impact on CD8(+) T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients\u2019 survival and ICB response","volume":"42","author":"Palermo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168440_bb0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Sautes-Fridman","year":"2016","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168440_bb0175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41577-023-00884-8","article-title":"Localization, tissue biology and T cell state - implications for cancer immunotherapy","volume":"23","author":"Schenkel","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168440_bb0180","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41590-023-01678-9","article-title":"Decoding the tumor microenvironment with spatial technologies","volume":"24","author":"Walsh","year":"2023","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168440_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbadis.2026.168440_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012224","article-title":"Tertiary lymphoid structures in Merkel cell carcinoma facilitate naive and central memory T-cell infiltration linked to immunotherapy response","volume":"13","author":"Srinivas","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168440_bb0195","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/cancers6020969","article-title":"Role of tertiary lymphoid structures (TLS) in anti-tumor immunity: potential tumor-induced cytokines\/chemokines that regulate TLS formation in epithelial-derived cancers","volume":"6","author":"Pimenta","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168440_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2017.07.019","article-title":"T cell zone resident macrophages silently dispose of apoptotic cells in the lymph node","volume":"47","author":"Baratin","year":"2017","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168440_bb0205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint blockade immunotherapy induces dynamic changes in PD-1(\u2212)CD8(+) tumor-infiltrating T cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2026.168440_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02728","article-title":"Renal cell carcinoma (RCC) tumors display large expansion of double positive (DP) CD4+CD8+ T cells with expression of exhaustion markers","volume":"9","author":"Menard","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168440_bb0220","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168440_bb0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12943-024-02000-3","article-title":"R-loop and diseases: the cell cycle matters","volume":"23","author":"Xu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.bbadis.2026.168440_bb0230","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s12276-025-01495-0","article-title":"R-loops: a key driver of inflammatory responses in cancer","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:20:31Z","timestamp":1790986831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926003066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926003066"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168440","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-cancer single-cell atlas of immunotherapy response identifies ZNF385A as a regulator of immune evasion in small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168440"}}